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Realizing Potential: 
A Pragmatic Look at Human Embryonic Stem Cell Research 
 
Mark L. Bentley 
 
In the United States, there are over 400,000 cryogenically frozen embryos (Hoffman, et al., 
2003).  These frozen embryos are almost exclusively produced from in vitro fertilization (IVF) 
and related treatments. Much debate centers on the fate of these embryos.  Among the current 
options available to the parents of leftover embryos are embryo adoption, keeping the embryos 
frozen for future use, destroying them, faux-implantations to let the embryos „naturally‟ die 
(Grady, 2008), and donating them for human embryonic stem cell (hES cell) research. While not 
all of the embryos are destroyed, many are, and it is wasteful for those embryos to simply be 
discarded.  With the consent of the parents, researchers should use the embryos slated to be 
destroyed or discarded for the purpose of realizing the great potential they posses, rather than 
letting them be wasted.  
Thousands of embryos created via IVF are destroyed or discarded each year (Harvard, 2008). In 
fact, over the last 14 years there have been over one million embryos destroyed in the UK alone 
(Woolf, 2007).  Many frozen embryos are destroyed because of circumstances: the death of the 
donor parents, loss of contact with the parents, divorce, or the parents simply do not want to use 
the embryos or put them up for adoption.  Some say that the surplus frozen embryos should be 
placed for adoption instead of being destroyed. However, while there are several groups working 
for and towards this end, for every embryo that is donated to others, more than 100 embryos are 
still discarded (Michigan, 2009).  There simply are not enough people willing to adopt all of the 
existing unused embryos. 
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Numerous embryos also are discarded as medical waste because they cannot be used for fertility 
treatments, due to genetic defects or abnormal development. These embryos, while unfit for IVF 
because they either will not implant in the uterus, or have a much lower chance for implantation, 
can be used as a source of hES cells.  Even in nature, these embryos would have the same low- to 
no- implantation rate, or would be subject to spontaneous abortion. Thus, in any scenario, these 
embryos have very little, if any, chance of survival.  They are not being used.  They are not even 
being stored as the healthy embryos that are often later destroyed, and they also would have been 
destroyed naturally had their conception taken place in vivo. 
In addition to circumstances, genetic defects, and abnormal development, there are many other 
reasons that embryos are destroyed, but whatever the reason, embryos are being destroyed or 
discarded. In this context the question is not “should these embryos have been created?”  Nor is 
it “should they be destroyed?”  They were created, and they are being destroyed.  The question 
is, why shouldn‟t they be used for good? 
First, one might argue that we do not have the power to choose how the embryos are used 
because the embryos cannot give consent.  Let‟s assume, for the sake of analogy, that a man is 
unconscious, and being kept alive by life support systems. The doctor informs the man‟s wife 
that he will not regain consciousness, and will remain in this state as long as she keeps the life 
support systems on. For ethically reasonable and justifiable reasons, she decides to withdraw the 
life support, and then informs the doctor that she would like to donate his organs. This is carried 
out, and many lives are saved.  
Donating embryos that are slated for destruction is similar to donating the organs or body of an 
individual who is dying.  In the case of the organ or body donor, we do not always require the 
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consent of the individual, as in the above analogy.  In the absence of a living will, a surrogate 
often has to decide on behalf of a person who is unconscious.  In case of the embryos, the parents 
make the decision of what to do with the embryos. The parents may decide, instead of simply 
destroying the embryos, to let them be used in ways that can benefit others. In fact, about 66% of 
patients say they are willing to donate embryos for stem cell research (Grady, 2008). 
While it is true that hES cell research destroys persons, it is also true that only two options exist: 
these persons can be destroyed with no possibility of benefit to others, or they can be destroyed 
with great possibility of benefit to others. The ethics of taking human life are clear.  However, 
when the option to save the life does not exist, is it not possible that deciding on behalf of other 
people that their deaths will be useless, when they cannot decide for themselves, also unethical?  
Second, one might argue that hES cell research itself is unnecessary because hES cells are not 
the only type of stem cell research being pursued. However, the research related to hES cells has 
been largely impaired, not because hES cell research does not have enormous potential 
(Andrews, et al., 2005), but because of the ethical debate centered on hES cell research 
(Abhishek, 2008). That debate has been the reason behind the recent initiative to find alternatives 
for hES cells in regenerative medicine (Abhishek, 2008). Alternatives include Pluripotent 
Aminotic Epithelium Cells, Trophoblast-derived Stem Cells, Endometrial Regenerative Cells, 
Placental-derived Stem Cells, Umbilical Cord Blood Stem Cells, Amniotic Fluid Stem Cells, 
Adult Stem Cells, and Induced Pluripotent Stem Cells (Abhishek, 2008). Some of these 
alternatives show great promise, but still researchers hold them to the benchmark of the potential 
of hES cell research. For example, research is being conducted using embryonic stem cells to 
cure kidney, liver, heart, blood, nervous system, and other diseases and injuries (Leslie, 2006). 
The researchers hypothesize that stem cells from just one particular source won‟t be able to cure 
Realizing Potential  4 
all of these diseases, but rather that “most likely, each disease will have its own preferred 
source,” (Van de Stolpe, et al., 2005). Further, recent studies have shown that we are getting 
closer to realizing some of the potential of hES cells. Leslie (2006) cites several examples of hES 
cell advances, such as genetic marker recognition, production of ectodermal, mesodermal, and 
endodermal lineages, and even disease-specific lines of hES cells. 
Additionally, Hyun (2009) argues that other promising forms of stem cell research, specifically 
induced pluripotent stem (iPS) cells, requires that hES cells develop alongside iPS cells to better 
understand the iPS cell technology.  “[T]he use of human embryonic stem cells is absolutely 
essential in increasing our understanding of iPS cells.” Hyun argues: “if you are going to make 
an artificial version of a human embryonic stem cell, you had better know everything you can 
learn about the real deal” (Hyun, 2009). 
I am not arguing that embryos should be created with the sole purpose of being used in hES cell 
research, that we establish labs to create embryos for research purposes only. Neither am I 
arguing that we should encourage the destruction of embryos, or that we should use embryos that 
might be destroyed.  hES cell research should only use embryos that are being destroyed, and the 
embryos must be willingly donated by parents for the purpose of research that could potentially 
save many lives and cure diseases.  Under these circumstances, hES cell research does not have 
to be an additional destruction of life.  Rather, if realized, the potential that hES cell research 
holds could save the lives, or significantly improve the quality of life, for millions of people. 
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